LEADER 03766nam 22005055 450 001 9910484419903321 005 20250609110029.0 010 $a981-15-3910-3 024 7 $a10.1007/978-981-15-3910-7 035 $a(CKB)4100000011273140 035 $a(MiAaPQ)EBC6207048 035 $a(DE-He213)978-981-15-3910-7 035 $a(PPN)248393537 035 $a(MiAaPQ)EBC6207002 035 $a(EXLCZ)994100000011273140 100 $a20200519d2020 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aRapid On-Site Evaluation (ROSE) in Diagnostic Interventional Pulmonology $eVolume 3: Neoplastic Diseases /$fedited by Jing Feng, Qiang Li, Hongwu Wang, Faguang Jin, Hongmei Zhou 205 $a1st ed. 2020. 210 1$aSingapore :$cSpringer Singapore :$cImprint: Springer,$d2020. 215 $a1 online resource (173 pages) $cillustrations 311 08$a981-15-3909-X 327 $aRapid on-site evaluation (ROSE) in diagnostic interventional pulmonology -- Anatomic distribution and morphology of common tracheal/bronchial/pulmonary cells -- Cellular characteristics of ROSE in pulmonary solid malignancies -- ROSE cytopathology cases. 330 $aThis book offers cutting-edge evidence on using rapid on-site evaluation (ROSE) for the diagnosis of neoplastic diseases in pulmonology. ROSE has become an efficient interventional diagnostics tool and important reference for lung disease differentiation, increasing the adequacy rate, diagnostic yield and accuracy of interventional pulmonary procedures. By performing a rapid stain in the bronchoscopy suite, with evaluation by a trained physician, ROSE can be used to ensure the collection of suitable and sufficient material for ancillary studies in an era of caner-targeted therapy. ROSE holds considerable value in terms of evaluating sampling adequacy for further immunohistochemistry testing, microbiology studies, flow cytometry analysis, and molecular assays, providing a preliminary diagnosis for patient care. The first part of the book discusses the key principles for performing ROSE procedures and reviews key anatomical structures in the lung. It also covers typical cellular characteristics on the ROSE scale for pulmonary solid malignancies. The second part of the book features abundant figures and illustrations of ROSE cytopathology in common neoplastic diseases, e.g. adenocarcinoma, squamous-cell carcinoma and small cell lung cancer, while also exploring more unusual types, e.g. pneumonia-type carcinoma of the lung (PTCL), mucinous adenocarcinoma, lung mixed carcinoma, pulmonary metastases from extrapulmonary primary tumors, large cell neuroendocrine carcinoma (LCNEC), and lymphoma. This book is part of the 4-volume collection ROSE in Diagnostic Interventional Pulmonology. 606 $aRespiratory organs?Diseases 606 $aPneumology/Respiratory System$3https://scigraph.springernature.com/ontologies/product-market-codes/H33134 615 0$aRespiratory organs?Diseases. 615 14$aPneumology/Respiratory System. 676 $a780 702 $aFeng$b Jing$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aLi$b Qiang$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aWang$b Hongwu$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aJin$b Faguang$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aZhou$b Hongmei$4edt$4http://id.loc.gov/vocabulary/relators/edt 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910484419903321 996 $aRapid On-Site Evaluation (ROSE) in Diagnostic Interventional Pulmonology$91737466 997 $aUNINA